Debiopharm Partners with Genedata to Digitalize Translational Research

Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy

Endor Labs Receives Intellyx Digital Innovation Award

Endor Labs, a startup securing open source software (OSS) and the supply chain, has received the Intellyx Digital Innovation Award, which recognizes technology providers who make it through the analyst firm’s rigorous briefing selection process – leading-edge vendors driving enterprise digital transformation.

For Canadian Pharmacies, AI Conquers a Mountain of Faxed Prescriptions

For Canadian Pharmacies, AI Conquers a Mountain of Faxed Prescriptions

Expert.ai Launches AI Platform for Life Sciences

Expert.ai Platform for Life Sciences strengthens solutions and industry practice honed by expert.ai from real-world implementations with global organizations and scientific publishers such as Sanofi, New England Journal of Medicine, EBSCO, 3M Health, and INSERM. Our new Platform for Life Sciences has been chosen as a “Best of Show” finalist for 2023 Bio-IT Awards!

New Partnership Established: Alfa Chemistry Adds 200,000+ Chemicals to Spaya Database

Rhapsody Names New Chief Financial Officer

Summary of Large-Scale RNA Synthesis Methods

Speeding Up The Cancer Drug Discovery Process with Zebrafish Disease Models

Form Bio Selected by Google Cloud to Help Organizations Adopt New AI-powered Life Sciences Solutions

Form Bio, the breakthrough computational life sciences platform, announced today that it has been selected to help organizations adopt Google Cloud’s Multiomics Suite, accelerating the research of life science companies and academic institutions. In addition, Form Bio has been designated by Google as a Google Cloud Premier partner.

Inizio Targets Innovation and AI-Led Growth with Two Top Appointments

Global strategic advisory agency Inizio has announced two senior leadership appointments to its Inizio Medical division, strengthening the AI and innovation capabilities of the business.

Prescription Screening Process Analysis Provides New Possibilities for Pharmaceutical Industry

OMICSEDGE FORMS STRATEGIC PARTNERSHIP WITH ALMADEN GENOMICS TO STREAMLINE DRUG DISCOVERY

OmicsEdge has launched an industry leading drug discovery service that leverages Almaden’s g.nome™ platform to streamline the iteration process. The service makes it easy for labs to conduct a quick analysis of a patient or trial participant’s medical condition and genomics, gaining valuable insight in genomic criteria and how it affects elevated risk. It can be used to significantly accelerate the drug discovery process and eliminate trial-and-error with abilities such as identifying causal variants that make ideal drug targets.

The Next Era of AI Drug Discovery? Quantum Computing

A consortium of international scientists has taken the first step toward incorporating quantum computing into AI-powered drug discovery.

CD Genomics Unveils Cutting-Edge Long-Read Metagenomic Sequencing Service

CD Genomics Expands Services with Pre-made Library Sequencing for High-Throughput Analysis

CD Genomics Harnesses Single-cell DNA Methylation Sequencing Service to Drive Scientific Breakthroughs

New Course Provides Expert Insights on AI Disease Modeling and Target Discovery

Generative artificial intelligence (AI)-driven drug discovery company Insilico Medicine is offering a new, free online course on Disease Modeling and Target Identification. Designed for a broad audience that includes researchers, scientists, pharmaceutical professionals, and students, the course provides lessons from leading experts at Insilico, including biologists, application scientists, and bioinformaticians.

PEGS Week 2023: Creative Biolabs Unveils the Agenda

Creative Biolabs is ready for the PEGS Boston Summit, which will exhibit at booth 205 from May 15–19.

PharmaVigil Automates PV Literature Activities with PubHive

European Consulting and Safety Services Provider Adopts PubHive’s Validated Drug Safety and Pharmacovigilance Software Platform to Automate Literature Surveillance and Screening

Alfa Chemistry’s Journey at Pittcon 2023 and ACS Spring 2023 Has Come to a Fruitful and Joyful End

Alfa Chemistry, a leading provider of analytical chemistry services, has successfully concluded its participation in two major industry events—Pittcon 2023 and the ACS Spring 2023 meetings. The events offered a unique opportunity for the company to showcase its services, connect with industry experts, and stay up to date with the latest advances in the field of analytical chemistry.